A case of methamphetamine use disorder treated with the antibiotic drug minocycline

Yuko Tanibuchi1, Minoru Shimagami, Goro Fukami

  • 1Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan. aguadebeber11@yahoo.co.jp

General Hospital Psychiatry
|September 21, 2010
PubMed

Insights

Methamphetamine use disorder can cause psychosis and brain damage. Minocycline, an anti-inflammatory drug, successfully improved psychotic symptoms in a patient with methamphetamine use disorder, suggesting potential for future clinical trials.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Methamphetamine (METH) use disorder is a global public health issue.
  • Long-term METH use is linked to dependence, psychosis, and neuroinflammation via activated microglia.
  • Neuroinflammation plays a role in METH-induced brain damage and associated psychotic symptoms.

Observation:

  • A case study of a female patient with METH use disorder experiencing psychotic symptoms is presented.
  • The patient received treatment with the anti-inflammatory drug minocycline.
  • Significant improvement in psychotic symptoms was observed following minocycline therapy.

Findings:

  • Minocycline therapy demonstrated efficacy in alleviating psychotic symptoms in a patient with METH use disorder.
  • The study highlights a potential therapeutic benefit of minocycline for METH-induced psychosis.
  • While mechanisms are unclear, minocycline's anti-inflammatory properties may contribute to its effectiveness.

Implications:

  • Minocycline shows promise as a potential therapeutic agent for METH use disorder, specifically for managing psychotic symptoms.
  • Further clinical trials are warranted to investigate minocycline's efficacy and safety in larger populations with METH use disorder.
  • This case suggests a novel avenue for medication development targeting neuroinflammation in substance use disorders.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...